Founded by skin cancer surgeon Dr Antony Nakhla in 2021, Eighth Day started with a single hero product, The Regenerative Serum, and launched exclusively into high-end specialty retailer Violet Grey.
The new appointment comes after the line received minority investment from private equity firm L Catterton in September.
Since its launch, Eighth Day has expanded to include more products such as eye cream and moisturiser, all leaning on ingredients such as peptide-rich plasma inspired by procedures from Dr Nakhla’s surgical career. The line is now also distributed in the likes of Neiman Marcus and Net-A-Porter.
Sachs joins from “clean” skincare line Tula, which was acquired by Procter & Gamble in 2022. Sachs ended her tenure as CEO there in July 2023. Dr Nakhla will move into a product development focused role, and is still working full time as a practising physician.
Learn more:
Puig Acquires Dr. Barbara Sturm
The Spanish beauty and fashion conglomerate has taken a majority stake in the German premium skincare brand.
